Josef Finsterer, MD, PhD*, Marlies Frank, MD. 2020. “Evidence Level for Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Respectively Sodium Glucose Co-Transporter-2 Inhibitors for Mitochondrial Diabetes Is Low”. Innovative Journal of Medical and Health Sciences 10 (06):959-60. https://innovativejournal.in/index.php/ijmhs/article/view/2988.